This is an automatically translated article.
Sulfaguanidin drug is often used to treat intestinal infections such as bacillus dysentery, diarrhea, enteritis. It also helps prevent infections before and after intestinal surgery.
1. What is Sulfaguanidin?
Sulfaguanidin 500mg drug has the main active ingredient Sulfaguanidine 0.5g with bacteriostatic effect, anti-parasitic, anti-bacterial, antiviral, antifungal.
Thanks to the above effect, the drug Sulfaguanidin is often indicated to treat the following cases:
Intestinal diseases: Inflammation of the small intestine; Acute colitis; Diarrhea caused by bacteria; The bacillus dysentery (bacillus dysentery); Intestinal disinfection before and after surgery. Sulfaguanidin 500mg is prepared and packaged in the form of tablets.
2. Instructions on how to take Sulfaguanidin
Sulfaguanidin drugs need to be used according to the instructions and prescriptions of the doctor. The following is a suggested dosage and is for reference only:
2.1. Dosage for adults For adults, take 8-12 Sulfaguanidin tablets/day, divided into 2-3 oral doses.
2.2. Dosage for children For children, the dose should be specified by a doctor. Normally, the reference dose of Sulfaguanidin for children is as follows:
Children under 1 year old: Take 2-4 tablets/day, divided into 2-3 oral doses; Children from 1-6 years old: Take 4-6 tablets/day, divided into 2-3 doses; Children from 7-15 years old: Take 8-10 tablets/day, divided into 2-3 doses; *Note:
Each course of medication lasts from 5-7 days. Patients should take this medicine with plenty of water. If diarrhea is infected, people need to take Sulfaguanidin in combination with antibiotics and take rehydration measures.
3. Sulfaguanidin side effects
In some cases, Sulfaguanidin can still cause some side effects such as:
Nausea and vomiting; Anorexia; There is a rash on the skin; Exfoliative dermatitis ; Sensitive reaction to light; Lyell's syndrome; Agranulocytosis; Aplastic anemia ; Thrombocytopenia, leukopenia; Decreased blood prothrombin; Eosinophilia (eosinophil) ; Decreased liver and kidney function. During the treatment period, if the patient develops the above side effects or other unusual symptoms appear on the skin, they should stop taking Sulfaguanidin 500mg and notify the doctor for support.
4. Note when using Sulfaguanidin
Do not use Sulfaguanidin 500mg for the following subjects:
Patients who are allergic to Sulfaguanidin or other ingredients of the drug; Deficiency of G6PD enzyme (Glucose-6- phosphate dehydrogenase); Children under 2 months old; Patients with hematopoietic disorders, acute porphyria, severe kidney disease, severe liver failure. Allergy to Sulfamids; Laboratory tests showed albuminuria, urinary retention. You need to be careful when using Sulfaguanidin 500mg in special cases such as pregnant women, nursing mothers, surgery... There are still not enough studies to determine the risks when taking this drug during pregnancy. pregnancy or lactation. Therefore, before taking the drug, the above subjects should consult a doctor to weigh the benefits and risks.
5. Sulfaguanidine drug interactions
Sulfaguanidin drugs rarely interact with other drugs because they are not absorbed from the gastrointestinal tract. However, Sulfaguanidine may still change the way other medicines you are taking work or increase the effects of side effects.
To limit this situation, the patient should write a list of the drugs they are taking (including prescription drugs, non-prescription drugs, herbs, dietary supplements) and show it to the doctor first. In addition, to ensure safety when taking the drug, the patient should not arbitrarily take the drug, stop or change the dose of the drug without informing or consulting the doctor.
Follow Vinmec International General Hospital website to get more health, nutrition and beauty information to protect the health of yourself and your loved ones in your family.
Please dial HOTLINE for more information or register for an appointment HERE. Download MyVinmec app to make appointments faster and to manage your bookings easily.
